| # | Drug | Count |
|---|---|---|
| 0 | NILOTINIB | 130 |
| 1 | IMATINIB | 56 |
| 2 | DASATINIB | 53 |
| 3 | IMATINIB MESYLATE | 44 |
| 4 | PONATINIB HYDROCHLORIDE | 34 |
| 5 | ASCIMINIB | 20 |
| 6 | CYTARABINE | 20 |
| 7 | HYDROXYUREA | 20 |
| 8 | ALLOPURINOL | 13 |
| 9 | BOSUTINIB | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PONATINIB HYDROCHLORIDE | 34 | 0.0065 |
| 1 | ASCIMINIB | 20 | 0.0057 |
| 2 | DASATINIB | 53 | 0.0057 |
| 3 | NILOTINIB | 130 | 0.0044 |
| 4 | IMATINIB MESYLATE | 44 | 0.0016 |
| 5 | BOSUTINIB | 12 | 0.0013 |
| 6 | ROPEGINTERFERON ALFA-2B | 2 | 0.0011 |
| 7 | HYDROXYUREA | 20 | 0.0009 |
| 8 | MEPIVACAINE HYDROCHLORIDE | 1 | 0.0009 |
| 9 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 2 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 2 | 0.0011 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 5 | Bile Acid [EPC] | 4 | 0.0002 |
| 6 | Azole Antifungal [EPC] | 20 | 0.0001 |
| 7 | Penem Antibacterial [EPC] | 4 | 0.0001 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |